Browsing Tag

peripheral nervous system

Enhancing peripheral nerve regeneration with neurotrophic factors and bioengineered scaffolds: a…

Abstract Despite the peripheral nervous system's (PNS) capacity to regenerate, functional restoration is highly variable following peripheral nerve injury (PNI), oftentimes leading to persistent functional deficits. In the preclinical…

Oxaliplatin‐ and docetaxel‐induced polyneuropathy: clinical and neurophysiological characteristics

Abstract To evaluate the presence and characterization of chemotherapy‐induced neuropathy (CIPN) and neuropathic pain 5 years after adjuvant chemotherapy with docetaxel or oxaliplatin. Patients from an ongoing prospective study, who had…

Incidence and mortality rates of Guillain‐Barré syndrome in Serbia

Abstract Background Guillain‐Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy. A huge variety of GBS incidence and mortality rates has been noted across the world. Aims The objective of the present multicentric study…

Expanding the phenotypic spectrum of TRIM2‐associated Charcot‐Marie‐Tooth disease

Abstract Background and Aims Charcot‐Marie‐Tooth disease (CMT) is a clinically and genetically heterogeneous group of distal symmetric polyneuropathies due to progressive and length‐dependent degeneration of peripheral nerves. Cranial…

Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy

Abstract Background and aims Ataxia pancytopenia (ATXPC) syndrome due to gain‐of‐function pathogenic variants in the SAMD9L gene has been described in 38 patients to date. It is characterized by variable neurological and hematological…

An international multicenter efficacy and safety study of IQYMUNE® in initial and maintenance…

Abstract Background and Aims This prospective, multicenter, single‐arm, open‐label phase 3 study aimed to evaluate the efficacy and safety of IqYmune® in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).…

Reliability of the Charcot‐Marie‐Tooth Functional Outcome Measure (CMT‐FOM)

Abstract Background and Aims The CMT‐FOM is a 13‐item clinical outcome assessment (COA) that measures physical ability in adults with Charcot‐Marie‐Tooth disease (CMT). Test‐retest reliability, internal consistency and convergent validity…